Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel crystal form of ribociclib monosuccinate and preparation method

A technology of monosuccinate and crystal form, which is applied in the field of medicine and can solve problems such as easy exceeding the standard

Active Publication Date: 2022-01-14
ANLITE SHANGHAI PHARMA TECH CO LTD +2
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The residual solvent of the amorphous prepared by this method is easy to exceed the standard

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel crystal form of ribociclib monosuccinate and preparation method
  • Novel crystal form of ribociclib monosuccinate and preparation method
  • Novel crystal form of ribociclib monosuccinate and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0134] Example 1: Preparation of crystal form AZT-IV

[0135] Weigh 5 mg of succinic acid and dissolve it in 1 mL of isopropanol, weigh 20 mg of compound (I) and suspend it in 1 mL of isopropanol, add dropwise the solution of succinic acid in isopropanol, filter, and vacuum-dry the filter cake at 40°C to obtain a solid . The obtained solid is the crystal form AZT-IV of the monosuccinate salt of the compound of formula (I).

[0136] Carry out XRPD test to the obtained solid, its X-ray powder diffraction pattern is as follows Figure 10 Shown; Carry out TGA test to gained solid, its spectrogram is as Figure 11 As shown, it has a weight loss of about 2.8% when heated to 100 ° C, which is a monohydrate; the resulting solid is subjected to DSC testing, and its spectrum is as follows Figure 12 As shown, the melting point is 182.7°C; 1 H-NMR test, the spectrum is basically as Figure 13 Shown, is monosuccinate.

Embodiment 2

[0137] Embodiment 2: Preparation of crystal form AZT-I

[0138] Weigh 5 mg of AZT-IV in the above Example 1, dissolve it in 1.5 mL of methanol, add 5 mL of diethyl ether dropwise, filter with suction, and dry the filter cake in vacuum at 35°C to obtain a solid, which is the monosuccinate crystal of the compound of formula (I) Type AZT-I.

[0139] Carry out XRPD test to the obtained solid, its X-ray powder diffraction pattern is as follows figure 1 Shown; Carry out TGA test to gained solid, its spectrogram is as figure 2 As shown, it has a weight loss of about 3.0% when heated to 100 ° C, which is a monohydrate; the resulting solid is subjected to DSC testing, and its spectrum is as follows image 3 As shown, the melting point is 183.0°C.

Embodiment 3

[0140] Embodiment 3: Preparation of crystal form AZT-II

[0141] Weigh 5 mg of AZT-IV in the above Example 1 and dissolve it in 1.5 mL of methanol, evaporate the methanol at room temperature to obtain a solid. The obtained solid is the monosuccinate crystal form AZT-II of the compound of formula (I).

[0142] Carry out XRPD test to the obtained solid, its X-ray powder diffraction pattern is as follows Figure 4 Shown; Carry out TGA test to gained solid, its spectrogram is as Figure 5 As shown, it has about 5.5% weight loss when heated to 100°C, which is dihydrate; DSC test is carried out on the obtained solid, and its spectrum is as follows Image 6 As shown, it has an exothermic peak at 159.2°C, and its melting point is 199.6°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to a new crystal form of ribociclib monosuccinate and a preparation method. Specifically, the present invention provides various new crystal forms of ribociclib monosuccinate (compound of the following formula) and preparation methods thereof, and the new crystal forms of the present invention have better stability and better solubility, And lower and safer solvent residues.

Description

[0001] field of invention [0002] The invention belongs to the field of medicine, in particular, it relates to 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-D]pyrimidine-6 - A new crystal form of the monosuccinate of carboxylic acid dimethylamide and a process for its preparation. [0003] Background of the invention [0004] Ribociclib (Ribociclib, trade name: KISQALI), developed by Novartis Pharmaceuticals Co., Ltd., Switzerland, is a cyclin-dependent kinase 4 / 6 (CDK4 / 6) inhibitor, used for the treatment of hormone receptor positive, human epidermis Growth factor receptor-2 negative (HR+ / HER2-) postmenopausal women with advanced or metastatic breast cancer. The chemical name of ribociclib is 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-D]pyrimidine-6-carboxy Acid dimethylamide, shown in its molecular structural formula (I): [0005] [0006] KISQALI uses ribociclib monosuccinate, but there are few studies on ribociclib monos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D487/04A61K31/519A61P35/00
CPCC07D487/04A61P35/00C07B2200/13
Inventor 尚婷婷张良
Owner ANLITE SHANGHAI PHARMA TECH CO LTD